Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.

Reviews in medical virology - 1 Jul 2021

Al-Eitan Laith N, Alahmad Saif Z

Abstract excerpt

The ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a significant challenge to international health. Pharmacogenomics aims to identify the different genetic variations that exist between individuals and populations in order to determine appropriate treatment protocols to enhance the efficacy of drugs and reduce their side-effects. This literature review provides an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to COVID-19
Share to COVID-19 Drug Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Genetic Predisposition to Disease

Share to Pharmacogenomic Testing

Share to Polymorphism, Genetic

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33205496
DOI: 10.1002/rmv.2194
PMCID: PMC7744885

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.PMID 33205496Read ↗

SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.Semantic proximity Read ↗

Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.Semantic proximity Read ↗

Role of SARS-CoV-2 and ACE2 variations in COVID-19.Semantic proximity Read ↗

Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.Semantic proximity Read ↗

ACE2 polymorphisms as potential players in COVID-19 outcome.Semantic proximity Read ↗

ACE2 polymorphisms as potential players in COVID-19 outcomeSemantic proximity Read ↗

SARS-CoV-2 Susceptibility and ACE2 Gene Variations Within Diverse Ethnic BackgroundsSemantic proximity Read ↗

COVID-19 genomic susceptibility: Definition of <i>ACE2</i> variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP GuidanceSemantic proximity Read ↗

SARS-CoV-2 susceptibility and <i>ACE2</i> gene variations within diverse ethnic backgroundsSemantic proximity Read ↗

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and TherapySemantic proximity Read ↗

Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19.Semantic proximity Read ↗

Clinical population genetic analysis of variants in the SARS-CoV-2 receptor ACE2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.